Regulating tuberculosis medical care and achieving no affected families facing catastrophic costs due to tuberculosis

doi:10.3969/j.issn.1000-6621.2019.05.004

Abstract

Abstract:

Tuberculosis (TB) is a disease closely related to poverty. With the government commitment, TB medical care are financed by government with free of charge services in many high TB-burden countries at present. However, the economic burden of TB patients for medical care is still heavy in some countries and the situation of catastrophic health costs due to TB is not optimistic. Direct medical cost has been the main economic burden to TB patients in China. An in-depth analysis on the composition of direct medical cost and the details of medical service could provide evidences on quality of TB medical care, and the relevance and necessity of each service. Understanding the direct medical costs is the premise to reduce the economic burden of TB patients and achieve the targets of “End TB” strategy.

Key words: Tuberculosis, Fees, medical, Cost of illness, Fee-for-service plans

Biao XU. Regulating tuberculosis medical care and achieving no affected families facing catastrophic costs due to tuberculosis[J]. Chinese Journal of Antituberculosis, 2019, 41(5): 485-487. doi: 10.3969/j.issn.1000-6621.2019.05.004

References 26

[1]	World Health Organization . Global tuberculosis report 2018. Geneva: World Health Organization, 2018.
[2]	程晓明 . 卫生经济学.北京: 人民卫生出版社, 2007.
[3]	Tanimura T, Jaramillo E, Weil D , et al. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J, 2014,43(6):1763-1775. doi: 10.1183/09031936.00193413 URL pmid: 4040181
[4]	World Health Organization, World Bank . Tracking universal health coverage: 2017 global monitoring report. Geneva: World Health Organization, 2017.
[5]	Fuady A, Houweling TAJ, Mansyur M , et al. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage. Infect Dis Poverty, 2018,7(1):3. doi: 10.1186/s40249-017-0382-3 URL pmid: 5765643
[6]	Qiu S, Pan H, Zhang S , et al. Is tuberculosis treatment really free in China? A study comparing two areas with different management models. PLoS One, 2015,10(5):e0126770. doi: 10.1371/journal.pone.0126770 URL pmid: 25993411
[7]	Xiang L, Pan Y, Hou S , et al. The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China. Infect Dis Poverty, 2016,5(8):8. doi: 10.1186/s40249-015-0094-5 URL pmid: 4730613
[8]	全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508.
[9]	Chimbindi N, Bor J, Newell ML , et al. Time and Money: The True Costs of Health Care Utilization for Patients Receiving “Free” HIV/Tuberculosis Care and Treatment in Rural KwaZulu-Natal. J Acquir Immune Defic Syndr, 2015,70(2):e52-60.
[10]	Berhanu RH, Schnippel K, Kularatne R , et al. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? Int J Tuberc Lung Dis, 2018,22(8):358-362. doi: 10.5588/ijtld.17.0837 URL
[11]	Asres A, Jerene D, Deressa W . Pre- and post-diagnosis costs of tuberculosis to patients on Directly Observed Treatment Short course in districts of southwestern Ethiopia: a longitudinal study. J Health Popul Nutr, 2018,37(1):15. doi: 10.1186/s41043-018-0146-0 URL
[12]	Getahun B, Wubie M, Dejenu G , et al. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis. Infect Dis Poverty, 2016,5(1):93. doi: 10.1186/s40249-016-0187-9 URL pmid: 5088676
[13]	姜世闻, 王黎霞 . 目标——因结核病导致家庭灾难性支出的患者为“零”. 中国防痨杂志, 2016,38(6):425-427. doi: 10.3969/j.issn.1000-6621.2016.06.001 URL
[14]	王姬, 应世栋, 张文伟 . 肺结核患者疾病经济负担及其影响因素分析. 实用预防医学, 2015,22(11):1352-1354. doi: 10.3969/j.issn.1006-3110.2015.011.023 URL
[15]	Pan HQ, Bele S, Feng Y , et al. Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China. Int J Tuberc Lung Dis, 2013,17(12):1575-1580.
[16]	Zhong J, Yin J, Zou G , et al. Experience of implementing the integrated TB model in Zhejiang, China: a retrospective observational study. Trans R Soc Trop Med Hyg, 2016,110(4):246-251. doi: 10.1093/trstmh/trw001 URL pmid: 26850456
[17]	Wang WB, Zhang H, Petzold M , et al. Cost-effectiveness of the Health X Project for tuberculosis control in China. Int J Tuberc Lung Dis, 2014,18(8):939-945. doi: 10.5588/ijtld.13.0131 URL pmid: 25199008
[18]	Ramma L, Cox H, Wilkinson L , et al. Patients’ costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa. Int J Tuberc Lung Dis, 2015,19(12):1513-1519.
[19]	Hu H, Chen J, Sato KD , et al. Factors that associated with TB patient admission rate and TB inpatient service cost: a cross-sectional study in China. Infect Dis Poverty, 2016,20(5):4. doi: 10.1186/s40249-016-0097-x URL pmid: 4719743
[20]	吴金伟, 姚晓英, 沈盾 . 初治肺结核患者门诊治疗费用影响因素分析. 预防医学, 2018,30(3):289-291. doi: 10.19485/j.cnki.issn2096-5087.2018.03.019 URL
[21]	陈民, 宋欢, 王金龙 , 等. 江苏省三级乙等医院肺结核患者住院费用分析. 现代预防医学, 2017,44(2):275-277.
[22]	杨林, 宁柱, 陈诚 , 等. 涂阳肺结核患者在定点医疗机构门诊的直接医疗费用及支付方式——一项基于江苏和四川部分地区的肺结核患者队列研究. 中国防痨杂志, 2019,41(5):556-563.
[23]	Xu B, Diwan VK, Bogg L . Access to tuberculosis care: what did chronic cough patients experience in the way of healthcare-seeking? Scand J Public Health, 2007,35(4):396-402. doi: 10.1080/14034940601160664 URL pmid: 17786803
[24]	Verguet S, Riumallo-Herl C, Gomez GB , et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Health, 2017,5(11):e1123-e1132.
[25]	杜世昌, 徐彩红, 王丽 , 等 . 新疆五县(区)肺结核患者医疗费用及经济负担现况的调查分析. 中国防痨杂志, 2018,40(6):609-615. doi: 10.3969/j.issn.1000-6621.2018.06.012 URL
[26]	张宏伟, 许静, 邓亚丽 , 等. 不同结算方式下汉中市肺结核患者门诊诊疗费用分析. 中国防痨杂志, 2018,40(11):1208-1213. doi: 10.3969/j.issn.1000-6621.2018.11.012 URL